NCT00247871 is a clinical trial in Nasal Colonization With MRSA Bacteria, sponsored by University of British Columbia.

Who is sponsoring NCT00247871?

NCT00247871 is sponsored by University of British Columbia.

What condition does NCT00247871 study?

NCT00247871 studies Nasal Colonization With MRSA Bacteria.

Is NCT00247871 still recruiting?

NCT00247871 is currently completed. Last updated 13 February 2025.

Last reviewed 2025-02-13 · How we verify

NCT00247871

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside

Completed Last updated 13 February 2025

What this trial tests

trial in Nasal Colonization With MRSA Bacteria in 600 participants. Completed in 1 December 2012.

Timeline

1 October 2005

Primary endpoint
1 December 2005

1 December 2012

Quick facts

Lead sponsor	University of British Columbia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	600
Start date	1 October 2005
Primary completion	1 December 2005
Estimated completion	1 December 2012
Sites	1 location across Canada

Conditions studied

Nasal Colonization With MRSA Bacteria — all drugs for Nasal Colonization With MRSA Bacteria →

Sponsor

University of British Columbia

Who can join

Eligibility, any sex, with Nasal Colonization With MRSA Bacteria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We plan to compare data from 300 nasal swab in Vancouver's Downtown Eastside taken in 2001 to data obtained in 2005. The nasal carriage rate of MRSA and the specific characteristic of each MRSA found will be analyzed. A limited amount of associated information will be obtained

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00247871 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 13 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00247871.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing